COVID - 19 Vaccination Update - Day 469 - Prevention is better than cure

Spread the Message

Read Time:1 Minute, 40 Second

Posted On: 29 APR 2022 8:13PM by PIB Delhi

India’s COVID-19 vaccination coverage has crossed 188.87 Crore (1,88,87,42,162) today. More than 20 lakh (20,30,807) Vaccine Doses have been administered till 7 pm today. The daily vaccination tally is expected to increase with the compilation of the final reports for the day by late tonight.

The cumulative coverage of vaccine doses, segregated based on population priority groups, is as follows:

Cumulative Vaccine Dose Coverage
HCWs	1^st Dose	10405106
	2^nd Dose	10016402
	Precaution Dose	4793359
FLWs	1^st Dose	18415663
	2^nd Dose	17539138
	Precaution Dose	7586150
Age Group 12-14 years	1^st Dose	28651935
	2^nd Dose	6545651
Age Group 15-18 years	1^st Dose	58420345
	2^nd Dose	42219391
Age Group 18-44 years	1^st Dose	555709198
	2^nd Dose	478049687
	Precaution Dose	147257
Age Group 45-59 years	1^st Dose	202917430
	2^nd Dose	187931817
	Precaution Dose	517864
Over 60 years	1^st Dose	126863397
	2^nd Dose	117086229
	Precaution Dose	14926143
Cumulative 1^st dose administered		1001383074
Cumulative 2^nd dose administered		859388315
Precaution Dose		27970773
Total		1888742162

Today’s achievement in the vaccination exercise, segregated by population priority groups, is as follows:

Date: 29^th April, 2022 (469^th Day)
HCWs	1^st Dose	57
	2^nd Dose	796
	Precaution Dose	15939
FLWs	1^st Dose	99
	2^nd Dose	1163
	Precaution Dose	40319
Age Group 12-14 years	1^st Dose	330196
	2^nd Dose	740720
Age Group 15-18 years	1^st Dose	46547
	2^nd Dose	132028
Age Group 18-44 years	1^st Dose	31449
	2^nd Dose	381652
	Precaution Dose	11775
Age Group 45-59 years	1^st Dose	4430
	2^nd Dose	83151
	Precaution Dose	34676
Over 60 years	1^st Dose	3295
	2^nd Dose	54749
	Precaution Dose	117766
Cumulative 1^st dose administered		416073
Cumulative 2^nd dose administered		1394259
Precaution Dose		220475
Total		2030807

The vaccination exercise as a tool to protect the most vulnerable population groups in the country from COVID-19 continues to be regularly reviewed and monitored at the highest level.